Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares Outstanding
Ratios

Enliven Therapeutics (ELVN) Shares Issued (2020 - 2026)

Enliven Therapeutics has reported Shares Issued over the past 7 years, most recently at $10.1 million for Q1 2026.

  • Quarterly results put Shares Issued at $10.1 million for Q1 2026, up 4196.15% from a year ago — trailing twelve months through Mar 2026 was $12.1 million (up 236.97% YoY), and the annual figure for FY2025 was $2.3 million, down 36.79%.
  • Shares Issued reached $10.1 million in Q1 2026 per ELVN's latest filing, up from $528000.0 in the prior quarter.
  • Across five years, Shares Issued topped out at $162.9 million in Q1 2023 and bottomed at -$161.1 million in Q3 2023.
  • Median Shares Issued over the past 5 years was $453000.0 (2024), compared with a mean of $998176.5.
  • Peak annual rise in Shares Issued hit 28329.32% in 2023, while the deepest fall reached 30800.0% in 2023.
  • Over 5 years, Shares Issued stood at $591000.0 in 2022, then crashed by 84.77% to $90000.0 in 2023, then surged by 403.33% to $453000.0 in 2024, then increased by 16.56% to $528000.0 in 2025, then surged by 1803.98% to $10.1 million in 2026.
  • Business Quant data shows Shares Issued for ELVN at $10.1 million in Q1 2026, $528000.0 in Q4 2025, and $209000.0 in Q3 2025.